Replies to post #204381 on Biotech Values

[DewDiligence]

AXON—I don’t have the data you requested, but please see the fourth paragraph of: http://www.fiercebiotech.com/r-d/axovant-rolls-into-phase-iii-a-risky-alzheimer-s-gambit . That should tell you what you need to know.